Kontrast Nefropatisi
Synopsis
Contrast-induced nephropathy (CIN) is a form of temporary acute kidney injury (AKI) that typically develops within three days following radiocontrast administration and is characterized by a significant increase in serum creatinine levels or a reduction in urine output. Historical advancements from high-osmolal ionic agents in the 1920s to low-osmolal and iso-osmolal non-ionic monomeric and dimeric compounds have markedly reduced osmotic toxicity, systemic hemodynamic adverse effects, and overall nephrotoxic potential. Pathophysiologically, CIN involves medullary hypoxia driven by prolonged reductions in renal blood flow, suppression of nitric oxide (NO) synthesis, elevated reactive oxygen species (ROS), endothelial dysfunction, and direct tubular epithelial cytotoxicity triggering caspase-mediated apoptosis. Pre-existing chronic kidney disease (eGFR < 60 mL/min/1.73 m²), diabetic nephropathy, congestive heart failure, dehydration, hypertension, advanced age, and high contrast volume represent the principal clinical risk factors. Prevention and clinical management rely primarily on administering the lowest effective contrast dose, maintaining hemodynamic stability, and ensuring rigorous pre- and post-procedural hydration using isotonic sodium chloride solutions.
References
Gaibi, T., Ghatak-Roy, A. (2019). Approach to Acute Kidney Injuries in the Emergency Department. Emergency Medicine Clinics of North America. Doi: 10.1016/j.emc.2019.07.006
Yavuz,Y.C., Sevinç, C., Tokgöz, B. (2017). Akut Böbrek Yetmezliği. Arınsoy, T., Güngör, Ö., Koçyiğit İ. (Eds.). Böbrek Fizyopatolojisi içinde (s.191-197). Reaktif
Luk L, Steinman J, Newhouse JH. Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea. Adv Chronic Kidney Dis. 2017May;24(3):169-175. doi: 10.1053/j.ackd.2017.03.001. PMID: 28501080.
Do C. Intravenous Contrast: Friend or Foe? A Review on Contrast-Induced Nephropathy. Adv Chronic Kidney Dis. 2017 May;24(3):147-149. doi: 10.1053/j.ackd.2017.03.003. PMID: 28501076.
Aydın, Ö.Ç., Aydın, S., Güney, H.Z. Kontrast Ajanlar; Farmakolojik Özellikleri, Genel Advers Reaksiyonları ve İlaç Etkileşimleri. Ankara Eğt. Arş. Hast. Derg. (Med. J. Ankara Tr. Res. Hosp.), 2020; 53(1): 61-67
Nyman, U., Ekberg, O., &Aspelin, P. (2016). TorstenAlmén (1931–2016): the father of non-ioniciodine contrast media. Acta Radiologica, 57(9), 1072–1078. Doi:10.1177/0284185116648504
Speck, U. (Ed.) (1999) Contrast Media. Doi: 10.1007/978-3-642-85995-3
Hudson KB, Sinert R. Renalfailure: emergency evaluation and management. EmergMedClin North Am. 2011 Aug;29(3):569-85. doi: 10.1016/j.emc.2011.04.005. PMID: 21782075.
Wilhelm-Leen, E., Montez-Rath, M. E., & Chertow, G. (2016). Estimating the Risk of Radiocontrast-Associated Nephropathy. Journal of the American Society of Nephrology, 28(2), 653–659. doi:10.1681/asn.2016010021
Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A. Acute kidney injury by radiographic contrast media: pathogenesis and prevention. BiomedResInt. 2014:362725. doi: 10.1155/2014/362725. Epub 2014 Aug 14. PMID: 25197639; PMCID: PMC4150431.
Weisbord SD, Palevsky PM. Contrast-associatedAcuteKidneyInjury. CritCareClin. 2015 Oct;31(4):725-35. doi: 10.1016/j.ccc.2015.06.008. Epub 2015 Jul 29. PMID: 26410140.
Moore A, Dickerson E, Dillman JR, et al. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material. Current Problems in Diagnostic Radiology. 2014 Sep-Oct;43(5):237-241. DOI: 10.1067/j.cpradiol.2014.05.001.
Davenport, M. S., Khalatbari, S., Cohan, R. H., & Ellis, J. H. (2013). Contrast Medium–induced Nephrotoxicity Risk Assessment in Adult Inpatients: A Comparison of Serum Creatinine Level– and Estimated Glomerular Filtration Rate–based Screening Methods. Radiology, 269(1), 92–100